Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation

CONTEXT AND OBJECTIVE: Non-myeloablative hematopoietic stem cell transplantation (NMA-HSCT) is performed in onco-hematological patients who cannot tolerate ablative conditioning because of older age or comorbidities. This approach does not completely eliminate host cells and initially results in mix...

Full description

Bibliographic Details
Main Authors: Azulamara da Silva Ruiz, Maria de Lourdes Ferrari Chauffaille, Solivanda Trindade Alves, José Salvador Rodrigues de Oliveira
Format: Article
Language:English
Published: Associação Paulista de Medicina
Series:São Paulo Medical Journal
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802009000500002&lng=en&tlng=en
_version_ 1819021507214442496
author Azulamara da Silva Ruiz
Maria de Lourdes Ferrari Chauffaille
Solivanda Trindade Alves
José Salvador Rodrigues de Oliveira
author_facet Azulamara da Silva Ruiz
Maria de Lourdes Ferrari Chauffaille
Solivanda Trindade Alves
José Salvador Rodrigues de Oliveira
author_sort Azulamara da Silva Ruiz
collection DOAJ
description CONTEXT AND OBJECTIVE: Non-myeloablative hematopoietic stem cell transplantation (NMA-HSCT) is performed in onco-hematological patients who cannot tolerate ablative conditioning because of older age or comorbidities. This approach does not completely eliminate host cells and initially results in mixed chimerism. Long-term persistence of mixed chimerism results in graft rejection and relapse. Involvement of graft-versus-host disease is concomitant with complete chimerism and graft-versus-tumor effect. The aim of this study was to evaluate the prevalence of chimerism in onco-hematological patients who underwent NMA-HSCT. DESIGN AND SETTING: Observational clinical study on chimerism status after human leukocyte antigen-identical NMA-HSCT at the Discipline of Hematology and Hemotherapy of Universidade Federal de São Paulo. METHODS: We sequentially analyzed the amplification of APO-B, D1S80, DxS52, FVW, 33.6, YNZ-2 and H-ras primers using variable number of tandem repeats (VNTR) on 17 pairs and fluorescent in situ hybridization (FISH) with the XY probe and SRY primer on 13 sex-unmatched pairs. RESULTS: The informativeness of the primers using VNTR was 60% for APO-B, 75% D1S80, 36% DxS52, 14% FVW, 40% YNZ-22 and 16% H-ras. The SRY primer was informative in female receptors with male donors. The XY-FISH method was informative in 100% of the sex-unmatched pairs. CONCLUSION: These methods were sensitive and informative. In VNTR, the association of APO-B with D1S80 showed 88% informativeness. The quantitative FISH method was more sensitive, but had the disadvantage of only being used for sex-unmatched pairs.
first_indexed 2024-12-21T04:08:12Z
format Article
id doaj.art-3667abd64c464079aff7c9ffda32ab8e
institution Directory Open Access Journal
issn 1806-9460
language English
last_indexed 2024-12-21T04:08:12Z
publisher Associação Paulista de Medicina
record_format Article
series São Paulo Medical Journal
spelling doaj.art-3667abd64c464079aff7c9ffda32ab8e2022-12-21T19:16:33ZengAssociação Paulista de MedicinaSão Paulo Medical Journal1806-9460127525125810.1590/S1516-31802009000500002S1516-31802009000500002Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantationAzulamara da Silva Ruiz0Maria de Lourdes Ferrari Chauffaille1Solivanda Trindade Alves2José Salvador Rodrigues de Oliveira3Universidade Federal de São PauloUniversidade Federal de São PauloHospital Santa MarcelinaUniversidade Federal de São PauloCONTEXT AND OBJECTIVE: Non-myeloablative hematopoietic stem cell transplantation (NMA-HSCT) is performed in onco-hematological patients who cannot tolerate ablative conditioning because of older age or comorbidities. This approach does not completely eliminate host cells and initially results in mixed chimerism. Long-term persistence of mixed chimerism results in graft rejection and relapse. Involvement of graft-versus-host disease is concomitant with complete chimerism and graft-versus-tumor effect. The aim of this study was to evaluate the prevalence of chimerism in onco-hematological patients who underwent NMA-HSCT. DESIGN AND SETTING: Observational clinical study on chimerism status after human leukocyte antigen-identical NMA-HSCT at the Discipline of Hematology and Hemotherapy of Universidade Federal de São Paulo. METHODS: We sequentially analyzed the amplification of APO-B, D1S80, DxS52, FVW, 33.6, YNZ-2 and H-ras primers using variable number of tandem repeats (VNTR) on 17 pairs and fluorescent in situ hybridization (FISH) with the XY probe and SRY primer on 13 sex-unmatched pairs. RESULTS: The informativeness of the primers using VNTR was 60% for APO-B, 75% D1S80, 36% DxS52, 14% FVW, 40% YNZ-22 and 16% H-ras. The SRY primer was informative in female receptors with male donors. The XY-FISH method was informative in 100% of the sex-unmatched pairs. CONCLUSION: These methods were sensitive and informative. In VNTR, the association of APO-B with D1S80 showed 88% informativeness. The quantitative FISH method was more sensitive, but had the disadvantage of only being used for sex-unmatched pairs.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802009000500002&lng=en&tlng=enVariable number of tandem repeatsHematologic neoplasmsBone marrow transplantationIn situ hybridization, fluorescenceChimerismLeukemia
spellingShingle Azulamara da Silva Ruiz
Maria de Lourdes Ferrari Chauffaille
Solivanda Trindade Alves
José Salvador Rodrigues de Oliveira
Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
São Paulo Medical Journal
Variable number of tandem repeats
Hematologic neoplasms
Bone marrow transplantation
In situ hybridization, fluorescence
Chimerism
Leukemia
title Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
title_full Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
title_fullStr Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
title_full_unstemmed Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
title_short Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
title_sort prevalence of chimerism after non myeloablative hematopoietic stem cell transplantation
topic Variable number of tandem repeats
Hematologic neoplasms
Bone marrow transplantation
In situ hybridization, fluorescence
Chimerism
Leukemia
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802009000500002&lng=en&tlng=en
work_keys_str_mv AT azulamaradasilvaruiz prevalenceofchimerismafternonmyeloablativehematopoieticstemcelltransplantation
AT mariadelourdesferrarichauffaille prevalenceofchimerismafternonmyeloablativehematopoieticstemcelltransplantation
AT solivandatrindadealves prevalenceofchimerismafternonmyeloablativehematopoieticstemcelltransplantation
AT josesalvadorrodriguesdeoliveira prevalenceofchimerismafternonmyeloablativehematopoieticstemcelltransplantation